期刊文献+

乳腺癌组织中bag-1、ER和PR的表达及意义 被引量:3

Expression and significance of bag-1 gene,ER and PR in human breast cancer
在线阅读 下载PDF
导出
摘要 目的检测bag-1,ER和PR在乳腺癌组织中的表达与分布情况,探讨bag-1、ER和PR的表达水平在乳腺癌发病、早期诊断方面的价值。方法采用免疫组化SABC法观察了100例乳腺癌与35例乳腺良性肿瘤及10例正常乳腺组织的石蜡标本切片中bag-1,ER和PR的表达与分布情况。结果bag-1在乳腺癌组织中,乳腺良性肿瘤中,正常乳腺组织中阳性表达率分别为85.0%,11.5%,10.0%,差异明显(P<0.05)。ER在乳腺癌组织中,乳腺良性肿瘤中,正常乳腺组织中阳性表达率分别为61.0%,28.6%,30.0%,差异明显(P<0.05)。PR在乳腺癌组织中,乳腺良性肿瘤中,正常乳腺组织中阳性表达率分别为64.0%,31.5%,30.0%,差异明显(P<0.05)。结论在乳腺癌发病过程中,bag-1,ER和PR可能起着重要的作用,同时检测bag-1、ER和PR的表达与分布情况,在乳腺癌的早期诊断方面有一定价值。 Objective To study the expression of bag-1 gene,estrogen recepter(ER) and progesterone recepter(PR)in breast cancer and to evaluate thier clinical significance. Methods SABC immunohistochemical stain was used to detect the expression of bag-1,ER and PR in 100 cases of breast cancer specimens , 35 cases of benign tumor and 10 cases of normal tissues.Results The positive rates of bag-1 expression among breast cancer , benign tumor and normal tissues were 85.0%,11.5%,10.0% respectively,and significant difference were observed (P<0.05). The positive rates of ER expression among breast cancer , benign tumor and normal tissues were 61.0%,28.6%,30.0% respectively,and significant difference were observed (P<0.05). The positive rates of PR expression among breast cancer , benign tumor and normal tissues were 64.0%,31.5%,30.0% respectively,and significant difference were observed (P<0.05).Conclusion The expression of bag-1,ER and PR may play a significant role in tumorigenesis and early diagnosis in breast cancer.
出处 《现代肿瘤医学》 CAS 2005年第4期464-465,共2页 Journal of Modern Oncology
关键词 BAG-1 ER PR 免疫组化 乳腺癌 bag-1 ER PR immunohistochemistry breast cancer
  • 相关文献

参考文献7

二级参考文献66

  • 1[1] Fuqua SAW,Fitzgerald SD, Chamness GC, et al.Variant human breast tumor estrogen receptor with constitutive transcriptional activity[J].Cancer Res,1991,51:105.
  • 2[2] Rio MC,Bellocq JP, Daniel JY, et al.Breast cancer-associated pS2 protein:synthesis and secretion by normal stomach mucosa[J].Science,1988,241:705.
  • 3[3] Diez Gibert 0,Machuca Z,Sebastian MA, et al. Expression of pS2 protein in breast cancer and its relationship with estrogen and progesterone receptors. Med Clin Barc,1996,107(3):90.
  • 4[4] Kawabata K, Watanabe K, Ozaki S. Expression of pS2-protein in breast cancer[J].Rinsho Byori,1996,44(7):647.
  • 5[5] Racca S, Conti G, Pietribiasi, et al. Correlation between pS2 protein positivity, steroid receptor status and other progrostic factors in breast cancer[J].Int J Biol Markers,1995,10:87.
  • 6[6] Gion M, Mione R, Pappagallo Gl, et al. pS2 in breast cancer alternative or complementary tools of steroid receptor status? Evaluation of 446 cases.[J].Br J Cancer,1993,68:374.
  • 7[7] Yano M, Naito Z, Tanaka S, et al. Expression and roles of heat shock proteins in human breast cancer[J].Jpn J Cancer Res,1996,87:908.
  • 8[8] Ciocca DR, Oesterreich S, Chamness GC,et al.Biological and clinical implications of heat shock protein 27,000(Hsp27):a review[J].J Natl Cancer Inst,1993,85:1558.
  • 9[9] Dunn DK, Whelan RD, Hill B, et al.Relationship of HSP27 and oestrogen teceptor in hormone sensitive and insensitive cell lines[J].J Steroid Biochem Mol Biol,1993,46:469.
  • 10[10] Love S, King RJ. A 27 Kda heat shock protein that has anomalous prognostic powers in early and advanced breast cancer[J].Br J Cancer, 1994,69:743.

共引文献71

同被引文献27

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部